Sanofi Q3 2018 Performance Confirms Return to Growth
Third quarter 2018 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
With the performance we delivered in the third-quarter, Sanofi has returned to growth. We have delivered on our promise to shareholders, while bringing important new medicines and treatments to patients around the world
Chief Executive Officer